Alternatives to time-consuming, error-prone operations promise to reduce vaccine manufacturing costs and improve facility flexibility.
Leonard Mestrandrea
Advertisement
LeonardMestrandrea is principal of Mestrandrea Consulting LLC.
Articles by Leonard Mestrandrea
Advertisement
Latest Updated Articles
Moving to Closed Systems for Aseptic ProcessingPublished: November 15th 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
2
Establishing Risk Assessments for AI in Bio-Manufacturing
3
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
4
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
5
